These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15060721)

  • 1. Dual inhibition of 5-lipoxygenase/cyclooxygenase by a reconstituted homeopathic remedy; possible explanation for clinical efficacy and favourable gastrointestinal tolerability.
    Jäggi R; Würgler U; Grandjean F; Weiser M
    Inflamm Res; 2004 Apr; 53(4):150-7. PubMed ID: 15060721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
    Ye YN; Wu WK; Shin VY; Bruce IC; Wong BC; Cho CH
    Carcinogenesis; 2005 Apr; 26(4):827-34. PubMed ID: 15637091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
    Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
    Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase.
    Araico A; Terencio MC; Alcaraz MJ; Domínguez JN; León C; Ferrándiz ML
    Life Sci; 2006 May; 78(25):2911-8. PubMed ID: 16360707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation.
    Ergün BC; Nuñez MT; Labeaga L; Ledo F; Darlington J; Bain G; Cakir B; Banoglu E
    Arzneimittelforschung; 2010; 60(8):497-505. PubMed ID: 20863006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: regulating factors for interleukin 1beta synthesis.
    Marcouiller P; Pelletier JP; Guévremont M; Martel-Pelletier J; Ranger P; Laufer S; Reboul P
    J Rheumatol; 2005 Apr; 32(4):704-12. PubMed ID: 15801029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
    Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of action of the new antiinflammatory compound ML3000: inhibition of 5-LOX and COX-1/2.
    Tries S; Neupert W; Laufer S
    Inflamm Res; 2002 Mar; 51(3):135-43. PubMed ID: 12005204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells.
    Hayashi T; Nishiyama K; Shirahama T
    Int J Urol; 2006 Aug; 13(8):1086-91. PubMed ID: 16903934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphonuclear leucocytes in vitro.
    Moilanen E; Alanko J; Asmawi MZ; Vapaatalo H
    Eicosanoids; 1988; 1(1):35-9. PubMed ID: 2856170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory activity of tryptanthrin on prostaglandin and leukotriene synthesis.
    Danz H; Stoyanova S; Thomet OA; Simon HU; Dannhardt G; Ulbrich H; Hamburger M
    Planta Med; 2002 Oct; 68(10):875-80. PubMed ID: 12391548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
    Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
    Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of (E)-3-(4-methanesulfonylphenyl)-2-(aryl)acrylic acids as dual inhibitors of cyclooxygenases and lipoxygenases.
    Moreau A; Chen QH; Praveen Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7716-27. PubMed ID: 16931030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX, LOX and platelet aggregation inhibitory properties of Lauraceae neolignans.
    Coy ED; Cuca LE; Sefkow M
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6922-5. PubMed ID: 19880317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis.
    Vidal C; Gómez-Hernández A; Sánchez-Galán E; González A; Ortega L; Gómez-Gerique JA; Tuñón J; Egido J
    J Pharmacol Exp Ther; 2007 Jan; 320(1):108-16. PubMed ID: 17015640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation.
    Schühly W; Hüfner A; Pferschy-Wenzig EM; Prettner E; Adams M; Bodensieck A; Kunert O; Oluwemimo A; Haslinger E; Bauer R
    Bioorg Med Chem; 2009 Jul; 17(13):4459-65. PubMed ID: 19481465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade.
    Tavolari S; Bonafè M; Marini M; Ferreri C; Bartolini G; Brighenti E; Manara S; Tomasi V; Laufer S; Guarnieri T
    Carcinogenesis; 2008 Feb; 29(2):371-80. PubMed ID: 18033773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.